These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 31109944)

  • 1. Mystery Solved: IL-15.
    Fehniger TA
    J Immunol; 2019 Jun; 202(11):3125-3126. PubMed ID: 31109944
    [No Abstract]   [Full Text] [Related]  

  • 2. Interleukin (IL)-2 and IL-15 have different effects on human natural killer lymphocytes.
    Pillet AH; Thèze J; Rose T
    Hum Immunol; 2011 Nov; 72(11):1013-7. PubMed ID: 21925225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 15: a potential player during the innate immune response to infection.
    Carson WE; Caligiuri MA
    Exp Parasitol; 1996 Nov; 84(2):291-4. PubMed ID: 8932779
    [No Abstract]   [Full Text] [Related]  

  • 4. Transpresentation of interleukin-15 by IL-15/IL-15Rα mRNA-engineered human dendritic cells boosts antitumoral natural killer cell activity.
    Van den Bergh J; Willemen Y; Lion E; Van Acker H; De Reu H; Anguille S; Goossens H; Berneman Z; Van Tendeloo V; Smits E
    Oncotarget; 2015 Dec; 6(42):44123-33. PubMed ID: 26675759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I IFN signaling on dendritic cells is required for NK cell-mediated anti-tumor immunity.
    Karimi K; Karimi Y; Chan J; Boudreau JE; Basset J; Chew MV; Reid S; Bramson JL; Wan Y; Ashkar AA
    Innate Immun; 2015 Aug; 21(6):626-34. PubMed ID: 25749844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-15 in cancer immunotherapy: IL-15 receptor complex versus soluble IL-15 in a cancer cell-delivered murine leukemia model.
    Berger A; Colpitts SJ; Seabrook MSS; Furlonger CL; Bendix MB; Moreau JM; McKillop WM; Medin JA; Paige CJ
    J Immunother Cancer; 2019 Dec; 7(1):355. PubMed ID: 31856922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin (IL)-15R[alpha]-deficient natural killer cells survive in normal but not IL-15R[alpha]-deficient mice.
    Koka R; Burkett PR; Chien M; Chai S; Chan F; Lodolce JP; Boone DL; Ma A
    J Exp Med; 2003 Apr; 197(8):977-84. PubMed ID: 12695489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Converting IL-15 to a superagonist by binding to soluble IL-15R{alpha}.
    Rubinstein MP; Kovar M; Purton JF; Cho JH; Boyman O; Surh CD; Sprent J
    Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9166-71. PubMed ID: 16757567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical role for IL-15 in innate immunity.
    Ohteki T
    Curr Mol Med; 2002 Jun; 2(4):371-80. PubMed ID: 12108948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokines: shared receptors, distinct functions.
    DiSanto JP
    Curr Biol; 1997 Jul; 7(7):R424-6. PubMed ID: 9210372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NK cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on DCs.
    Morandi B; Mortara L; Carrega P; Cantoni C; Costa G; Accolla RS; Mingari MC; Ferrini S; Moretta L; Ferlazzo G
    Int Immunol; 2009 May; 21(5):599-606. PubMed ID: 19325034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutting edge: murine dendritic cells require IL-15R alpha to prime NK cells.
    Koka R; Burkett P; Chien M; Chai S; Boone DL; Ma A
    J Immunol; 2004 Sep; 173(6):3594-8. PubMed ID: 15356102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-15 and IL-15Ralpha in CD4+T cell immunity.
    Van Belle T; Grooten J
    Arch Immunol Ther Exp (Warsz); 2005; 53(2):115-26. PubMed ID: 15928580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-2 and IL-15 manifest opposing effects on activation of nuclear factor of activated T cells.
    Eicher DM
    Cell Immunol; 2003 Jun; 223(2):133-42. PubMed ID: 14527511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-α primes T- and NK-cells for IL-15-mediated signaling and cytotoxicity.
    Hansen ML; Woetmann A; Krejsgaard T; Kopp KL; Søkilde R; Litman T; Straten PT; Geisler C; Wasik MA; Odum N; Eriksen KW
    Mol Immunol; 2011 Sep; 48(15-16):2087-93. PubMed ID: 21813181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coordinate expression and trans presentation of interleukin (IL)-15Ralpha and IL-15 supports natural killer cell and memory CD8+ T cell homeostasis.
    Burkett PR; Koka R; Chien M; Chai S; Boone DL; Ma A
    J Exp Med; 2004 Oct; 200(7):825-34. PubMed ID: 15452177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential roles for IL-15R alpha-chain in NK cell development and Ly-49 induction.
    Kawamura T; Koka R; Ma A; Kumar V
    J Immunol; 2003 Nov; 171(10):5085-90. PubMed ID: 14607906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-2, interleukin-15, and their roles in human natural killer cells.
    Becknell B; Caligiuri MA
    Adv Immunol; 2005; 86():209-39. PubMed ID: 15705423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interleukin-15/interleukin-15 receptor system as a model for juxtacrine and reverse signaling.
    Bulfone-Paus S; Bulanova E; Budagian V; Paus R
    Bioessays; 2006 Apr; 28(4):362-77. PubMed ID: 16547946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The IL-15 cytokine system provides growth and survival signals in Hodgkin lymphoma and enhances the inflammatory phenotype of HRS cells.
    Ullrich K; Blumenthal-Barby F; Lamprecht B; Köchert K; Lenze D; Hummel M; Mathas S; Dörken B; Janz M
    Leukemia; 2015 May; 29(5):1213-8. PubMed ID: 25486870
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.